First-Dose and Steady-State Sampling Choices

Why the Dosing Occasion Matters

A concentration measured four hours after a first dose does not necessarily answer the same question as a concentration measured four hours after a later dose. On the first occasion, the measured concentration reflects that dose. After repeated doses, residual drug from earlier doses may contribute as well. The sampling occasion therefore matters alongside the time elapsed since the most recent dose.

First-dose samples are useful for observing the concentration-time profile before prior doses contribute. Steady-state samples describe the recurring profile under a repeated regimen, including accumulation and concentrations near the peak or trough. When both are collected at matched times after dosing, their difference can help characterize accumulation. When sampling times differ, the concentration change may instead reflect the rise or fall within the dosing interval.

Definition: First-dose sampling collects concentrations after the initial dose, before any earlier doses in the regimen can contribute. Steady-state sampling collects concentrations after repeated dosing has produced a stable, recurring concentration-time profile for the regimen. A sample's postdose time is the elapsed time from the most recent dose to that sample.

A Model for Understanding Accumulation

A simple model makes the comparison precise. Consider repeated equal intravenous bolus doses given every \(\tau\) hours to a one-compartment system with linear elimination and constant elimination rate \(k\) per hour. Let \(C_0\), in mg/L, be the immediate concentration increase produced by one dose. After a single dose, concentration at time \(t\) hours is \(C_1(t)=C_0e^{-kt}\), for \(t\geq0\). This illustrative model assumes the dose is instantaneous, elimination is first-order, and PK parameters do not change over time.

With repeated dosing, the concentration after the latest dose is the sum of the latest dose's contribution and the residual contributions from earlier doses. If the sample is \(t\) hours after a dose, with \(0\leq t<\tau\), the steady-state concentration is a geometric series:

C_{\mathrm{ss}}(t)=C_0e^{-kt}\left(1+e^{-k\tau}+e^{-2k\tau}+\cdots\right) =\frac{C_0e^{-kt}}{1-e^{-k\tau}}.

The series converges because \(0<e^{-k\tau}<1\) for \(k>0\) and \(\tau>0\). The factor \(1/(1-e^{-k\tau})\) is the accumulation factor for concentrations at the same postdose time under this model. It describes the ratio of the steady-state concentration to the concentration from one dose alone at that same time; it is not, by itself, a universal multiplier for every PK model or dose form.

Key result: Under linear, time-invariant PK, concentrations from separate doses add. Thus a first-dose and steady-state comparison at the same postdose time isolates the contribution of prior doses in the model. Comparing samples taken at different postdose times mixes accumulation with the within-interval concentration change.

Worked Comparisons

Worked Example: Comparing Matched Postdose Times

Suppose a hypothetical IV bolus regimen gives \(C_0=5.00\ \mathrm{mg/L}\), with \(k=0.100\ \mathrm{h}^{-1}\) and \(\tau=8.00\ \mathrm{h}\). Compare the first-dose and steady-state concentrations at \(t=4.00\ \mathrm{h}\) after the most recent dose. Assume the model above applies and dosing and sampling times are exact.

First dose. No prior dose contributes, so

C_1(4.00)=5.00e^{-(0.100)(4.00)} =5.00e^{-0.400} =5.00(0.670320) =3.352\ \mathrm{mg/L}.

Steady state. Here \(e^{-k\tau}=e^{-(0.100)(8.00)}=e^{-0.800}=0.449329\). Therefore,

C_{\mathrm{ss}}(4.00) =\frac{3.35160}{1-0.449329} =\frac{3.35160}{0.550671} =6.086\ \mathrm{mg/L}.

At the matched postdose time, using the unrounded concentrations, the difference is approximately \(2.735\ \mathrm{mg/L}\), attributable to residual contributions from prior doses under the stated model. If instead the steady-state four-hour concentration were compared with the first-dose concentration immediately after dosing, the comparison would also include the decline from the initial concentration. It would not isolate accumulation.

Worked Example: Peak, Trough, and Accumulation

For a second hypothetical regimen, let the single-dose immediate concentration increase be \(C_0=3.00\ \mathrm{mg/L}\), with \(k=0.0500\ \mathrm{h}^{-1}\) and \(\tau=12.0\ \mathrm{h}\). Calculate the steady-state peak and trough for the bolus model. Assume the peak occurs immediately after a dose and the trough immediately before the next dose.

First calculate the fraction remaining after one interval: \(e^{-k\tau}=e^{-0.600}=0.548812\). The accumulation factor is

R=\frac{1}{1-e^{-k\tau}} =\frac{1}{1-0.548812} =2.21637 \approx 2.22.

The steady-state peak is \(C_0R\). Using the unrounded factor, the peak is \(3.00(2.21637)=6.649\ \mathrm{mg/L}\). The trough is the peak multiplied by the fraction remaining over the interval:

C_{\mathrm{trough,ss}} =6.64911(0.548812) =3.649\ \mathrm{mg/L}.

The peak-to-trough difference is approximately \(6.649-3.649=3.000\ \mathrm{mg/L}\), equal to the immediate concentration increase from one dose in this model. The peak-to-trough ratio is \(6.64911/3.64911\approx1.822\). These results describe a bolus model with first-order elimination; they should not be applied unchanged to oral dosing or to a regimen with a different concentration-time shape.

Worked Example: A Sample Before Steady State

Suppose the regimen in the first example begins at time zero, with doses at 0, 8, and 16 hours. A sample is taken at 20 hours, four hours after the third dose. Use the same hypothetical values \(C_0=5.00\ \mathrm{mg/L}\), \(k=0.100\ \mathrm{h}^{-1}\), and \(\tau=8.00\ \mathrm{h}\). Calculate the concentration and compare it with the eventual steady-state value at the same postdose time.

At 20 hours, the three doses have been present for 20, 12, and 4 hours, respectively. Their contributions are \(5.00e^{-0.400}=3.35160\ \mathrm{mg/L}\), \(5.00e^{-1.200}=1.50597\ \mathrm{mg/L}\), and \(5.00e^{-2.000}=0.676676\ \mathrm{mg/L}\). Adding them gives

C(20)=3.35160+1.50597+0.676676 =5.534\ \mathrm{mg/L}.

The eventual steady-state concentration at four hours after a dose was \(6.086\ \mathrm{mg/L}\). Thus the 20-hour sample is about \(5.534/6.086=0.9093\), or 90.9%, of that steady-state concentration. It is not appropriate to label this sample a steady-state observation merely because several doses have been given. In this example, the residual contributions from doses before the regimen began have not yet reached their limiting sum.

Choosing Between First-Dose and Steady-State Samples

The best occasion depends on the question. First-dose sampling can help describe the early profile following initiation, including absorption and the initial decline, without accumulation from earlier doses. It may be especially useful when the study question concerns the first administration or when steady-state sampling is impractical. It cannot, by itself, show the repeated-regimen peak, trough, or accumulation.

Steady-state sampling describes concentrations under the intended repeated regimen. Samples near the postdose peak and just before the next dose can characterize peak-to-trough variation; a predose sample is often used to describe the trough. A single steady-state sample at an unspecified point in the interval is harder to interpret: it does not automatically identify either the peak or the trough.

A design may use both occasions when it matters to distinguish the initial profile from the profile after accumulation. For an informative direct comparison, place samples at matched postdose times and record the actual dose and sample times. The following contrasts summarize the choices.

Sampling occasion	What it can describe	What it cannot establish alone
After the first dose	Initial concentration-time behavior without contributions from prior doses	Accumulation or the steady-state peak-to-trough profile
At steady state	Concentrations and variation over the repeated dosing interval	The first-dose profile, unless first-dose data are also collected
Both, at matched postdose times	Initial versus accumulated concentrations at comparable points in the interval	A causal explanation for a difference if PK or dosing conditions changed between occasions

For the simple model, the elimination half-life is \(t_{1/2}=\ln(2)/k\). Under linear, time-invariant PK, the approach to steady state is governed by this elimination rate. As a rough guide, four to five half-lives after starting a regimen leave about 6.25% to 3.13% of a single-dose transient, respectively. This is a useful planning approximation, not proof that steady state has been reached: absorption, distribution, a long terminal phase, missed doses, or changing PK may affect the practical assessment.

Assumptions, Diagnostics, and Common Pitfalls

The geometric accumulation calculation requires linear superposition: each dose must contribute the same concentration-time profile, and the total concentration must be the sum of those contributions. It also assumes a stable dosing interval, constant dose, unchanged clearance and other relevant PK properties, and a sufficiently long regimen for the steady-state approximation. If elimination is nonlinear or PK changes over time, the stated accumulation factor may be wrong. Oral dosing and infusions also have different concentration-time shapes; their peak timing and profile require a model that represents the route and input process.

Before interpreting a first-dose versus steady-state contrast, check the dose history, dose amounts, actual administration times, sample times, and whether doses were missed or changed. Check that the supposed steady-state samples were taken after enough repeated dosing for the relevant PK behavior. Examine whether the assay can quantify concentrations near the expected trough, and whether collection times really fall near the intended peak or trough. A mismatch between actual and nominal times can make two samples appear different even when the underlying profile is as expected.

Wrong comparison: comparing the first-dose peak with a later steady-state sample at four hours. Correction: compare at the same elapsed time after dosing if the goal is to isolate prior-dose contributions.
Calling any late dose steady state: several administrations do not guarantee a stable recurring profile. Correction: consider the elimination time scale and review the dose history and observed concentrations.
Using the accumulation factor outside its model: \(1/(1-e^{-k\tau})\) is not a general-purpose multiplier for every route, model, or nonlinear process. Correction: use a concentration-time model appropriate to the dose input and PK assumptions.
Interpreting a concentration as a peak or trough without its time: a concentration's meaning depends on its position in the dosing interval. Correction: document the most recent dose time and the sample's actual postdose time.

First-dose and steady-state designs are alternatives only when the scientific question is narrow. If the goal is initial disposition or absorption, first-dose sampling may be sufficient; if it is the repeated regimen's trough or peak-to-trough behavior, steady-state sampling is directly relevant. Collecting both can clarify the role of accumulation, but it requires additional samples and careful control of dose and sampling times. Neither occasion alone guarantees that all parameters or features of the concentration-time profile can be characterized.

Key takeaway: State both the dosing occasion and the postdose time when interpreting a concentration. Under a linear repeated-dose model, matched first-dose and steady-state samples distinguish the initial contribution from the added residual contributions of prior doses.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

Why is a first-dose sample at six hours not directly comparable with a steady-state peak if the aim is to assess accumulation?
For a hypothetical bolus regimen with \(k=0.0500\ \mathrm{h}^{-1}\) and \(\tau=12.0\ \mathrm{h}\), calculate the accumulation factor to three significant figures.
If \(C_0=3.00\ \mathrm{mg/L}\) for the regimen in question 2, calculate the steady-state peak and trough to three significant figures.
Name two conditions that can make the simple accumulation calculation inappropriate or misleading.

Solutions. (1) The samples are at different postdose times: the peak is near the dose, whereas the six-hour sample is later in the interval. The difference combines accumulation with the concentration decline after dosing. Compare first-dose and steady-state concentrations both at six hours to assess the prior-dose contribution under the model. (2) \(e^{-k\tau}=e^{-0.600}=0.548812\), so \(R=1/(1-0.548812)=2.21637\), which is \(2.22\) to three significant figures. (3) The steady-state peak is \(3.00(2.21637)=6.64911\ \mathrm{mg/L}\), or \(6.65\ \mathrm{mg/L}\) to three significant figures. The trough is \(6.64911(0.548812)=3.64911\ \mathrm{mg/L}\), or \(3.65\ \mathrm{mg/L}\). (4) Examples include nonlinear elimination, a changing dose or dosing interval, missed doses, changing clearance, and applying the bolus model to an oral regimen without accounting for absorption.